TABLE 2.
Demographics of recipients, living donors, and transplantations (N = 49)
| Recipients | |
|---|---|
| Median age at transplantation, y | 50 (range, 3–74; IQR, 38–59) |
| ABO blood group, % | |
| A | 29 |
| B | 10 |
| AB | 6 |
| O | 55 |
| Median BMI, kg/m2 | 24.5 (range, 13.5–31.9; IQR, 22.1–27.5) |
| Transplant number, % | |
| 1 | 65 |
| 2 | 29 |
| 3 | 4 |
| ≥4 | 2 |
| cPRA, % | |
| 80–100 | 33 |
| 20–79 | 49 |
| 0–19 | 18 |
| Female, % | 65 |
| Diagnosis, % | |
| Polycystic kidney disease | 21 |
| Chronic glomerulonephritis | 8 |
| IgA nephropathy | 14 |
| Renal vascular disease | 12 |
| Diabetes | 2 |
| Congenital renal hypoplasia | 6 |
| Chronic renal failure, cause uncertain | 16 |
| Miscellaneous | 21 |
| Induction therapy, % | |
| Basiliximab | 86 |
| None | 14 |
| Immunosuppression, % | |
| MMF, tacrolimus, steroids | 88 |
| MMF, tacrolimus | 8 |
| Everolimus, tacrolimus, steroids | 4 |
| Median waiting time before Tx, total, mo | 12.5 (range, 0–109; IQR, 8.8–23.3) |
| Dialysis before Tx, % | |
| Preemptive | 49 |
| 0–12 mo | 14 |
| 13–24 mo | 8 |
| 25–36 mo | 14 |
| ≥37 mo | 15 |
| Living donors | |
| Median age at donation, y | 47 (range, 26–70; IQR, 41–58) |
| ABO blood group, % | |
| A | 53 |
| B | 10 |
| AB | 4 |
| O | 33 |
| Median BMI, kg/m2 | 24.8 (range, 20.5–33.6; IQR, 23.9–28.0) |
| Female, % | 47 |
| Relation, % | |
| Spouse | 42 |
| Sibling | 12 |
| Friend | 12 |
| Son/daughter | 10 |
| Parent | 8 |
| Other relation | 8 |
| Anonymous donor | 8 |
| Transplantations | |
| Median CIT, min | 329 (range, 60–615; IQR, 223–429) |
| Broad HLA mismatches, % | |
| 0 HLA-A mismatches | 10 |
| 0 HLA-B mismatches | 2 |
| 0 HLA-DRB1 mismatches | 14 |
| 0 HLA-DQB1 mismatches | 53 |
BMI, body mass index; CIT, cold ischemia time; cPRA, calculated panel-reactive antibody; IgA, immunoglobulin A; IQR, interquartile range; MMF, mycophenolate mofetil; Tx, transplant.